“May all be happy, may all be healed, may all be at peace and may no one ever suffer."
Allogeneic bone marrow transplantation is a medical procedure in which bone marrow cells from a donor are transplanted into a patient whose own bone marrow has been damaged or destroyed. This procedure is used to treat various conditions including leukemia, lymphoma, multiple myeloma, and some genetic disorders.
The donor's bone marrow cells are transplanted through a procedure called infusion. Before the procedure, the patient undergoes chemotherapy and/or radiation to destroy the existing bone marrow cells in their body. The donor cells are then infused into the patient's bloodstream, where they travel to the bone marrow and begin producing new blood cells.
Allogeneic bone marrow transplantation carries significant risks, including rejection of the donor cells, graft-versus-host disease (GVHD), and infections. However, it can also be a potentially curative treatment for certain conditions. The success of the procedure depends on factors such as the age and health of the patient, the type of disease being treated, and the compatibility of the donor.